Fable Therapeutics

Headquarters
Cambridge
Business Model
B2B
Last Round
Series AOct 2024
Rounds
2

About

Fable Therapeutics applies advanced machine learning and computational protein design to develop novel therapeutics for obesity and cardiometabolic disease. The team includes veteran biotech executives and protein engineers, including scientists trained in Nobel laureate David Baker's protein-design lab at the University of Washington, and is backed by investors such as Versant Ventures and DCVC.

Summary

Fable Therapeutics is an Artificial Intelligence company based in Cambridge. Its most recent funding was a Series A round in Oct 2024. Investors include Jerel Davis, DCVC (Data Collab) and Omega Funds.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2024

Sign up to see all 2 rounds

Series A through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Fable Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/fable-therapeutics"><img src="https://indexed.vc/api/badge/company/fable-therapeutics" alt="Fable Therapeutics on Indexed.vc" width="260" height="76" /></a>